California Cancer Assocaties for Research & Excellence
1 clinical trials · Sponsor
◉ Watch California Cancer Assocaties for Research & Excellence
| Record | Firm | Date |
|---|---|---|
| Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma (NCT02142335) | California Cancer Assocaties for Research & Excellence | 2014-03-01 |
Track California Cancer Assocaties for Research & Excellence automatically
Every clearance here is in the API, with alerts when new ones post.